US Stock MarketDetailed Quotes
SGMO Sangamo Therapeutics
- 0.971
- +0.044+4.73%
Close Oct 15 16:00 ET
- 0.970
- -0.001-0.10%
Post 20:01 ET
202.20MMarket Cap-703P/E (TTM)
0.999High0.886Low3.88MVolume0.927Open0.927Pre Close3.70MTurnover2.05%Turnover RatioLossP/E (Static)208.22MShares1.48052wk High8.52P/B184.15MFloat Cap0.29152wk Low--Dividend TTM189.63MShs Float51.375Historical High--Div YieldTTM12.20%Amplitude0.291Historical Low0.951Avg Price1Lot Size
Sangamo Therapeutics Stock Forum
Sign in to post a comment
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
I really hope to see the auspicious number 3.2 next week
$Sangamo Therapeutics (SGMO.US)$
This legal step underscores Sangamo's efforts to ensure its corporate actions comply with legal standards and underscores the company's commitment to its stockholders' interests. The outcome of the hearing will determine the definitive status of the common stock increase amendment. This information is based on a press release statement
Sangamo seeks court validation for stock amendment By Investing.com
This legal step underscores Sangamo's efforts to ensure its corporate actions comply with legal standards and underscores the company's commitment to its stockholders' interests. The outcome of the hearing will determine the definitive status of the common stock increase amendment. This information is based on a press release statement
Sangamo seeks court validation for stock amendment By Investing.com
$Sangamo Therapeutics (SGMO.US)$ let's go baby!
1
$Sangamo Therapeutics (SGMO.US)$ $1 tonight?
1
$Sangamo Therapeutics (SGMO.US)$
Gene Editing Therapeutics Market Report 2024, Featuring Profiles of Key Players Allogene Therapeutics, CRISPR Therapeutics, Intellia Therapeutics, Sangamo Therapeutics and Vertex Pharmaceuticals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Gene Editi
https://www.moomoo.com/t/news/post/43596799/BYnzVJBmba
Gene Editing Therapeutics Market Report 2024, Featuring Profiles of Key Players Allogene Therapeutics, CRISPR Therapeutics, Intellia Therapeutics, Sangamo Therapeutics and Vertex Pharmaceuticals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Gene Editi
https://www.moomoo.com/t/news/post/43596799/BYnzVJBmba
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
WillLaw : Hope so, 41k shares here